1.Cost-utility analysis of rezivertinib versus gefitinib as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer
Xiaowei ZHU ; Tongming ZHU ; Jia YI ; Wenqiang LI ; Piaopiao LU ; Aizong SHEN
China Pharmacy 2026;37(1):55-60
OBJECTIVE To evaluate the cost-effectiveness of rezivertinib versus gefitinib as first-line treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC) from the perspective of the Chinese healthcare system. METHODS A Markov model was constructed based on the REZOR trial data, with a cycle length of 3 weeks and a study duration of 5 years. Both costs and health outcomes were discounted at an annual rate of 5%. A cost-utility analysis was conducted using 3 times China’s 2024 per capita gross domestic product as the willingness-to-pay (WTP) threshold. The economic differences between the rezivertinib regimen versus the gefitinib regimen were evaluated using the incremental cost- effectiveness ratio (ICER) and incremental net monetary benefit (INMB). Sensitivity and scenario analyses were performed to verify the robustness of the model. RESULTS Compared to the gefitinib regimen, the rezivertinib regimen saved 225 310.47 yuan and gained an additional 0.57 quality- adjusted life years (QALYs), resulting in an ICER of -395 562.80 yuan/QALY, which was much lower than the WTP threshold of this study, indicating that rezivertinib had an absolute economic advantage. The INMB analysis (389 041.26 yuan) further validated this conclusion. One-way and probabilistic sensitivity analyses confirmed the robustness of the model. Scenario analysis, incorporating a 15% reduction in drug prices and adjustments to the utility values for progression free survival and progression disease, yielded consistent results with the base case analysis. CONCLUSIONS Compared to gefitinib, rezivertinib as a first-line treatment for EGFR mutation-positive advanced NSCLC has an absolute economic advantage.
2.Value of metabolic markers combined with anthropometric indicators in predicting and risk stratification of metabolic dysfunction-associated fatty liver disease and establishment of a nomogram model
Sirui ZHAO ; Zheyu LI ; Wenqiang HE ; Junfeng LI ; Liting ZHANG
Journal of Clinical Hepatology 2026;42(5):1056-1066
ObjectiveTo develop a novel clinical predictive model for metabolic dysfunction-associated fatty liver disease (MAFLD) based on metabolic markers and anthropometric indicators, and to provide a more effective tool for the early screening and intervention of MAFLD. MethodsA retrospective analysis was performed for 2 824 individuals who underwent abdominal color Doppler ultrasound at Health Examination Center of The First Hospital of Lanzhou University from January 1, 2024 to January 1, 2025, and at a ratio of 7∶3, they were randomly divided into training set with 1 976 patients and validation set with 848 patients. Clinical data, serological markers, and abdominal ultrasound results were collected from all patients, and triglyceride-glucose (TyG) index, triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio, and anthropometric indicators were calculated. The independent samples t-test was used for comparison of normally distributed or approximately normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of continuous data with skewed distribution between two groups; the chi-square test or the Fisher’s exact test was used for comparison of categorical data between groups. The multivariate logistic regression analysis was used to identify independent predictive factors for MAFLD and intermediate- to high-risk MAFLD. Five risk prediction models were established for MAFLD based on the independent influencing factors, and a nomogram was plotted. The receiver operating characteristic (ROC) curve was plotted to assess model performance, and the area under the ROC curve (AUC) was calculated. The calibration curve was used to evaluate the predictive accuracy of the models, and decision curve analysis was used to assess the clinical practicability of the models. These models were then compared with traditional models. ResultsAmong the 1 976 individuals in the training set, 937 (47.42%) were diagnosed with MAFLD, and 423 (21.41%) were diagnosed with intermediate- to high-risk MAFLD; among the 848 individuals in the validation set, 406 (47.88%) were diagnosed with MAFLD. The multivariate logistic regression analysis showed that male sex (odds ratio [OR]=0.23, 95% confidence interval [CI]: 0.13 — 0.39, P<0.05), waist circumference (OR=1.11, 95%CI: 1.06 — 1.17, P<0.05), alanine aminotransferase (ALT) >40 U/L (OR=2.24, 95%CI: 1.44 — 3.51, P<0.05), high-density lipoprotein cholesterol (HDL-C) (OR=0.07, 95%CI: 0.04 — 0.15, P<0.05), TyG index (OR=8.27, 95%CI: 5.09 — 13.44, P<0.05), TG/HDL-C ratio (OR=0.84, 95%CI: 0.71 — 0.99, P<0.05), A Body Shape Index (ABSI) (OR=0.45, 95%CI: 0.39 — 0.52, P<0.05), and body roundness index (BRI) (OR=2.31, 95%CI: 1.50 — 3.55, P<0.05) were independent influencing factors for MAFLD, and male sex (OR=0.17, 95%CI: 0.10 — 0.31, P<0.05), age (OR=1.09, 95%CI: 1.07 — 1.11, P<0.05), hemoglobin (OR=0.98, 95%CI: 0.97 — 0.98, P<0.05), platelet count (OR=0.81, 95%CI: 0.70 — 0.93, P<0.05), fasting blood glucose (OR=0.80, 95%CI: 0.71 — 0.89, P<0.05), triglycerides (OR=0.14, 95%CI: 0.07 — 0.29, P<0.05), TG/HDL-C ratio (OR=0.78, 95%CI: 0.67 — 0.91, P<0.05), TyG index (OR=5.26, 95%CI: 3.32 — 8.33), waist circumference (OR=2.50, 95%CI: 1.72 — 3.61, P<0.05), ABSI (OR=0.58, 95%CI: 0.51 — 0.66, P<0.05), and BRI (OR=0.01, 95%CI: 0.00 — 0.21, P<0.05) were independent influencing factors for intermediate- to high-risk MAFLD. Among the five models established, model 5 (incorporating sex, ALT elevation, HDL-C, TyG index, TG/HDL-C ratio, waist circumference, and ABSI) had the best performance, with an AUC of 0.917 (95%CI: 0.905 — 0.929) in the training set and 0.911 (95%CI: 0.892 — 0.930) in the validation set. The calibration curve showed that model 5 had good predictive accuracy, and the decision curve analysis confirmed its clinical practicability. ConclusionThe predictive model for MAFLD constructed based on metabolic markers and anthropometric indicators has good discriminatory ability and can be used to assess the risk of MAFLD. In addition, this study shows that waist circumference, TyG index, TG/HDL-C ratio, ABSI, and BRI are independently associated with intermediate- to high-risk MAFLD, but further studies are needed to confirm their value in predicting liver fibrosis progression.
3.The diagnostic value of follow-up CT in pulmonary nodules progressing to invasive adenocarcinoma
Jia PENG ; Wenqiang ZHONG ; Kunwei LI ; Binghui CHEN
Journal of Practical Radiology 2025;41(10):1652-1657
Objective To investigate the natural progression of pulmonary ground-glass nodule(GGN)to invasive adenocarcinoma(IAC)and the diagnostic value of follow-up CT.Methods A retrospective analysis was performed on 45 GGN in 45 patients who were followed up for more than 2 years,surgically resected and pathologically confirmed.They were divided into IAC group(n=25)and non-IAC group(n=20),and the clinical and imaging characteristics between the two groups were compared.Results Significant differences were observed in initial volume(P=0.025),initial mass(P=0.005),margin(P=0.027),and time to GGN progression(P=0.005)between the IAC group and the non-IAC group.Multivariate logistic regression analysis indicated that initial mass and time to GGN progression were independent predictors for the diagnosis of IAC.The receiver operating characteristic(ROC)curve analysis results revealed that when using a maximum Youden's index of 0.456,the optimal cutoff for time to GGN progression was 30 months,with a sensitivity of 75.0%and a specificity of 70.6%,and an area under the curve(AUC)of 0.761[95%confidence interval(CI)0.606-0.916](P=0.005).When the maximum Youden's index reached 0.615,the sensitivity,specificity and AUC of the logistic regression model in the diagnosis of IAC were 79.2%,82.4%,and 0.860(95%CI 0.743-0.977)(P=0.001),respectively.The calibration curves demonstrated an excellent consistency between predicted and observed probabilities.Conclusion The optimal observation window for GGN is 30 months,during which IAC generally progresses.Close monitoring is recommended after the initiation of lesion growth.
4.Aromatase-positive astrocytes alleviate cerebral ischemia-reperfusion injury in mice
Tiantian XU ; Yumeng LI ; Yongheng YANG ; Wenqiang ZUO ; Jin WANG ; Shiquan WANG ; Haiyun GUO ; Wugang HOU
Chinese Journal of Neuroanatomy 2025;41(2):150-156
Objective:To investigate the role of reactive astrocytes expressing aromatase(ARO)in the penumbra during ischemic stroke.Methods:A mouse model of middle cerebral artery occlusion(MCAO/R)was prepared using the suture method.Western blot and immunofluorescence staining were used to observe the expression of ARO in the penumbra after ischemia reperfusion.We generated a glial fibrillary acidic protein promoter-driven aromatase knock-out(GFAP-ARO-KO)mouse model in vivo.Neurologic impairment scores,rotarod test,grip strength test and adhesive removal test on the plantar surface of the paw were performed after MCAO/R modeling.Results:In wild type mice,the expression of ARO was significantly increased in astrocytes in the penumbra after MCAO/R(P<0.01).Compared to the control group,the expression of ARO in the GFAP-ARO-KO group was significantly reduced in astrocytes in the penumbra after MCAO/R.And loss of ARO increased cerebral infarction volume and aggravated sensorimotor impair-ment.Conclusion:After ischemic stroke,reactive astrocytes in the penumbra highly express ARO and play a protective role in post-ischemia reperfusion injury.
5.Association of protein phosphatase 1 regulatory subunit 1B ( PPP1R1B) polymorphisms with schizophrenia in Han population of northern Henan province
Yanli LU ; Xiujuan WANG ; Zhaonian CHEN ; Xi SU ; Song LIU ; Yongfeng YANG ; Wenqiang LI
Chinese Journal of Behavioral Medicine and Brain Science 2025;34(2):131-137
Objective:To investigate the association between single nucleotide polymorphism (SNP) of the protein phosphatase 1 regulatory subunit 1B( PPP1R1B) gene and schizophrenia in the Han population of northern Henan province. Methods:Utilizing Psychiatric Genomics Consortium 3 (PGC3) data, the SNPs of PPP1R1B gene which were significantly associated with schizophrenia were screened.Subsequently, totally 1 721 schizophrenia patients and 6 726 healthy controls from the Han population in northern Henan province were recruited for further analysis. The SNP rs907094, located within the PPP1R1B gene was validated, and the clinical symptoms of 386 schizophrenia patients were evaluated using the positive and negative syndrome scale (PANSS). Additionally, expression quantitative trait loci (eQTL) association analysis was conducted to explore the relationship between the rs907094 polymorphism and PPP1R1B gene expression.The PLINK v1.9, Genetic Power Calculater, SPSS 20.0 softwares were used for data analysis. Results:Significant differences in genotype AA, AG, GG(schizophrenia group: AA, 489(28.4%); AG, 848(49.3%); GG, 384(22.3%); control group: AA, 1 450(21.6%); AG, 3 386(50.3%); GG, 1 890(28.1%), χ2=45.418, P<0.05) and allele frequency(schizophrenia group: A, 1 826(53.1%); G, 1 616(46.9%); control group: A, 6 286(46.7%); G, 7 166(53.3%), χ2=43.877, P<0.05) were observed for SNP rs907094 between the schizophrenia group and control group. Individuals carrying allele A were identified to have a higher risk of developing schizophrenia compared to those carrying allele G ( OR=1.288, 95% CI=1.195-1.388). Furthermore, the genotype PPP1R1B gene was found to be associated with the clinical features of schizophrenia. A statistically significant difference was observed in the excitement/hostility factor between AA and GG patients with rs907094 (13.62±5.65, 15.54±4.66)( P<0.05). Additionally, significant differences were noted in the cognitive factor scores between AA and GA genotypes (17.76±5.58, 19.43±5.73)( P<0.05). Conclusions:In the Han population from northern Henan province, the rs907094 polymorphism of the PPP1R1B gene is associated with schizophrenia.And the specific locus may be implicated in arousal/hostility symptoms and cognitive dysfunction.
6.Aromatase-positive astrocytes alleviate cerebral ischemia-reperfusion injury in mice
Tiantian XU ; Yumeng LI ; Yongheng YANG ; Wenqiang ZUO ; Jin WANG ; Shiquan WANG ; Haiyun GUO ; Wugang HOU
Chinese Journal of Neuroanatomy 2025;41(2):150-156
Objective:To investigate the role of reactive astrocytes expressing aromatase(ARO)in the penumbra during ischemic stroke.Methods:A mouse model of middle cerebral artery occlusion(MCAO/R)was prepared using the suture method.Western blot and immunofluorescence staining were used to observe the expression of ARO in the penumbra after ischemia reperfusion.We generated a glial fibrillary acidic protein promoter-driven aromatase knock-out(GFAP-ARO-KO)mouse model in vivo.Neurologic impairment scores,rotarod test,grip strength test and adhesive removal test on the plantar surface of the paw were performed after MCAO/R modeling.Results:In wild type mice,the expression of ARO was significantly increased in astrocytes in the penumbra after MCAO/R(P<0.01).Compared to the control group,the expression of ARO in the GFAP-ARO-KO group was significantly reduced in astrocytes in the penumbra after MCAO/R.And loss of ARO increased cerebral infarction volume and aggravated sensorimotor impair-ment.Conclusion:After ischemic stroke,reactive astrocytes in the penumbra highly express ARO and play a protective role in post-ischemia reperfusion injury.
7.Analysis concepts of traditional Chinese medicine in the diagnosis and treatment of heat stroke
Li KONG ; Hao HAO ; Feihu ZHANG ; Yu WANG ; Wenqiang LI ; Tejin BA ; Qianyu BI
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2025;32(1):11-15
The term"heat stroke"originates from the integration of modern traditional Chinese and Western medicine.In clinical practice,the complementary advantages of the two medical systems can significantly enhance the clinical diagnosis and treatment level of heat stroke.Through comprehensively analyzes the traditional Chinese medicine(TCM)nomenclature for heat stroke,proposing that heat stroke is a type of sunstroke characterized by intense and pure yang nature,specifically referring to symptoms caused directly or indirectly by hot weather.It can be referenced under the categories of Zhongye,Shuwen,Yinshu/Yangshu,Shujue,and Shufeng for treatment.The article reviews the TCM diagnostic and therapeutic thinking for heat stroke,summarizing its etiology and pathogenesis,including summerheat directly entering the Yangming,heat entering the heart and nutrient-blood aspects,evil combined with water(post-emergency),dual injury of qi and fluid(post-mild recovery),and phlegm-stasis obstructing collaterals(post-severe recovery).Based on years of clinical experience and combining the different clinical manifestations of heat stroke with TCM's four diagnostic methods,the article proposes a treatment plan that integrates Chinese and Western medicine,combining disease differentiation with syndrome differentiation.The main syndromes summarized include high fever with spasms(Yangming heat excess syndrome),diarrhea(Yangming fu syndrome-intestinal sweating),high fever with coma(heat entering the heart-nutrient syndrome),high fever with convulsions(extreme heat generating wind syndrome),heat stroke-induced coagulopathy(heat entering the blood aspect syndrome),edema after fluid resuscitation(Taiyang water retention syndrome),recovery phase(dual injury of qi and fluid syndrome),and sequelae(phlegm-stasis obstructing collaterals syndrome).For treatment,Baihu Jia Renshen decotion combined with Zengye Chengqi decotion is used for nourishing yin and increasing fluids,relaxing tendons,and stopping spasms for Yangming heat excess syndrome;Baihu decotion combined with Zengye decotion for clearing summerheat and nourishing yin for Yangming fu syndrome-intestinal sweating;Qingying decotion for clearing the nutrient aspect and cooling blood,penetrating heat,and nourishing yin for heat entering the heart-nutrient syndrome;Lingjiao Gouteng decotion for clearing heat and cooling the liver,extinguishing wind,and calming spasms for extreme heat generating wind syndrome;Wuling powder for draining and eliminating water retention for Taiyang water retention syndrome;Wang's Qing Shu Yiqi decotion for clearing summerheat and reducing fever,benefiting qi,and generating fluids for dual injury of qi and fluid syndrome;and Sanjia powder for clearing residual heat,resolving phlegm,and removing stasis from collaterals for phlegm-stasis obstructing collaterals syndrome.Starting from TCM theory and linking it with practice,the article combines Western disease differentiation with TCM syndrome differentiation,aiming to provide new ideas for the clinical treatment of heat stroke.
8.Surveillance and epidemic characteristics of human brucellosis in Inner Mongolia Autonomous Region from 2014 to 2023
Huidong LI ; Wenqiang ZHANG ; Ruiping YU ; Yue GONG
Chinese Journal of Endemiology 2025;44(9):741-745
Objective:To analyze the epidemic characteristics of human brucellosis in Inner Mongolia Autonomous Region, and to provide a basis for formulating targeted intervention strategies and implementation measures.Methods:The data of brucellosis cases with onset date from 2014 to 2023 and current address in Inner Mongolia Autonomous Region were collected from the Chinese Disease Control and Prevention Information System. Descriptive epidemiological method was used to analyze the three-dimensional distribution of human brucellosis in Inner Mongolia Autonomous Region.Results:From 2014 to 2023, a total of 131 201 brucellosis cases were reported in Inner Mongolia Autonomous Region, with no death and an average annual incidence rate of 52.90/100 000. The lowest incidence was in 2016 (6 567 cases, 26.15/100 000), and the highest was in 2021 (21 910 cases, 91.14/100 000). All 12 cities (leagues) in the region had reported cases of brucellosis, with Tongliao City (27 012 cases), Chifeng City (15 286 cases), Hinggan League (14 859 cases), Hulunbuir (12 235 cases) and Ulanqab (11 972 cases) ranking among the top 5 cities (leagues) in terms of reported cases. Among the cases, 90 455 (68.94%) were males, with a incidence rate of 70.93/100 000, and 40 746 (31.06%) were females, with a incidence rate of 33.70/100 000. The age of onset is mainly 50 and less than 60 years old (37 610 cases, 28.67%). The occupational distribution was mainly farmers (102 091 cases, 77.81%), followed by herdsmen (13 209 cases, 10.07%).Conclusions:The incidence of human brucellosis in Inner Mongolia Autonomous Region is at a relatively high level, particularly showing an upward trend from 2016 to 2021. Cities such as Tongliao City, Chifeng City and Hinggan League have a relatively high incidence of brucellosis. Therefore, it is necessary to strengthen the monitoring of brucellosis in these areas, implement prevention and control measures, and closely monitor the changes in the trend of human brucellosis outbreaks. Farmers and herdsmen are the primary high-risk groups, and it is recommended to enhance health education and behavioral interventions for these key populations.
9.Impact of ambient air pollution on hospital visits for mental and behavioral disorders among residents in an industrial area in Henan Province from 2016 to 2021
Yuhang CHEN ; Wenqiang ZHANG ; Junwei LIU ; Jirui ZHANG ; Zhengyang LIU ; Wenjun ZHANG ; Qingxin ZHANG ; Jinchan LIU ; Meng LI
Chinese Journal of Preventive Medicine 2025;59(1):39-52
Objective:To explore the impact of air pollution on hospital visits for mental and behavioral disorders among residents in an industrial area in Henan Province from 2016 to 2021.Methods:Daily outpatient visits data for mental and behavioral disorders were collected from Angang General Hospital in Angang Industrial Area at Anyang City between January 2016 and December 2021. And air pollutants and meteorological data during the same period were also collected. A generalized additive model was used for time-series analysis to examine the relationship between daily average concentrations of nitrogen dioxide (NO 2), sulfur dioxide (SO 2), fine particulate matter (PM 2.5), inhalable particulate matter (PM 10), carbon monoxide (CO), and ozone (O 3) with a lag of 0 to 7 days on the number of visits for mental and behavioral disorders among residents. The single-day lag effect (lag0-lag7 d) and cumulative lag effect (lag01-lag07 d) were analyzed. The smooth cubic spline function was used to fit the exposure-response relationship, and subgroup analysis was performed according to different genders, seasons and ages. Results:A total of 26 268 hospital visits for mental and behavioral disorders were collected from the industrial area between 2016 and 2021. The daily average concentrations of SO 2, NO 2, PM 2.5, PM 10, and CO were (27.50±27.33), (43.11±18.33), (73.87±60.30), (134.01±83.81) μg/m 3, and (1.72±1.03) mg/m 3, respectively. The daily maximum 8-hour average concentration of O 3 was (82.18±53.70) μg/m 3. After controlling for long-term trends, temperature, relative humidity, day of the week effects, and holiday effects, the generalized additive model analysis showed that NO 2 had a statistically significant impact on the hospital visits for mental and behavioral disorders at lag0 d, lag2 d and lag01-lag05 d and CO had a statistically significant impact at lag0-lag3 d and lag01-lag06 d (all P<0.05). NO 2 at lag02-lag04 d and CO at lag0-lag2 d and lag01-lag04 d had statistically significant effects on the visits for neurasthenia (both P<0.05). The impacts of NO 2 at lag03-lag04 d, PM 2.5 at lag3 d and lag03-lag04 d, PM 10 at lag3 d and lag03 d, and CO at lag3 d and lag01-lag05 d on visits for generalized anxiety disorder were also statistically significant (all P<0.05). After false discovery rate (FDR) correction, it was shown that for every 10 μg/m 3 increase in NO 2 and every 0.1 mg/m 3 increase in CO, the percentage increase in visits for mental and behavioral disorders and its 95% confidence interval (95% CI) were 3.38% (0.95%-5.87%) and 0.78% (0.38%-1.17%), respectively. For every 0.1 mg/m 3 increase in CO, the visits for neurasthenia increased by 0.78% (0.27%-1.29%). For every 10 μg/m 3 increase in PM 2.5 and every 0.1 mg/m 3 increase in CO, the visits for generalized anxiety disorder increased by 1.07% (0.46%-1.68%) and 1.17% (0.37%-1.97%), respectively (adjusted P<0.05). There was a linear exposure-response relationship between NO 2 and CO and the hospital visits for mental and behavioral disorders, CO and the hospital visits for neurasthenia, and CO and PM 2.5 and the hospital visits for generalized anxiety disorder ( P<0.05 for the overall association test and P>0.05 for the non-linearity test). Stratified analysis showed that air pollutants had an impact on male patients with neurasthenia, female patients with generalized anxiety disorder, individuals aged <45 years with mental and behavioral disorders, and individuals aged ≥65 years with generalized anxiety disorder. The impact of air pollutants was greater during the cold season or winter. Conclusion:Exposure to air pollution can increase hospital visits for mental and behavioral disorders among residents in industrial areas, with a higher risk among those aged<45 years old and during the cold season.
10.A Meta-analysis of serum selenium and cancer risk
Xiaolan WEN ; Jiayue LI ; Li LI ; Wenqiang WEI ; Shaoming WANG
Chinese Journal of Preventive Medicine 2025;59(5):561-571
Objective:To explore the association between serum selenium levels and total cancer risk in humans.Methods:A systematic search was conducted for Chinese and English literature on the association between selenium and cancer risk published up to December 2023 in the Chinese National Knowledge Infrastructure (CNKI), Wanfang, PubMed, EMbase, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL) databases by using “neoplasms” “selenium” “prospective-studies” (both in English and Chinese) as keywords. The meta-analysis was performed using a random-effect model. The linear dose-response relationship was analyzed using a generalized least squares regression model, and the non-linear dose-response relationship was analyzed using a restricted cubic spline regression model. Publication bias was assessed by funnel plots and Egger′s regression asymmetry test.Results:A total of 12 prospective studies were included from 16 408 articles retrieved, including seven studies from Europe, four from America, and one from Asia, with a total of 4 586 cancer cases reported. Meta-analysis revealed an inverse association between baseline serum selenium levels and total cancer risk ( RR=0.68, 95% CI: 0.57-0.82, P=0.000). Furthermore, serum selenium was found to have a protective effect on both the incidence ( RR=0.66, 95% CI: 0.53-0.84, P=0.001) and mortality ( RR=0.70, 95% CI: 0.50-0.98, P=0.035) of total cancer. The inverse association between serum selenium and the incidence of total cancer was more pronounced in populations with low baseline serum selenium levels ( RR=0.65, 95% CI: 0.48-0.89, P=0.007). Additionally, dose-response meta-analysis showed that for every 10 μg/L increase in baseline serum selenium concentration, there was a 26% reduction in incidence of total cancer ( RR=0.74, 95% CI: 0.46-0.83, P=0.229) and a 6% reduction in mortality of total cancer ( RR=0.94, 95% CI: 0.86-0.96, P=0.229). Conclusion:Serum selenium is negatively associated with the incidence and mortality of total cancer.

Result Analysis
Print
Save
E-mail